Amgen Inc. is a leading biotechnology company known for its innovative approach to developing human therapeutics. With a focus on areas of high unmet medical need, the company leverages its expertise in molecular biology and biochemistry to discover, develop, manufacture, and deliver innovative human therapeutics. Amgen's portfolio includes treatments for conditions such as cancer, kidney disease, rheumatoid arthritis, and other serious illnesses.

Amgen is committed to sustainability and has made significant strides in reducing its environmental impact. The company has set ambitious goals to reduce carbon emissions, water usage, and waste. Amgen's sustainability efforts are guided by its Environmental, Social, and Governance (ESG) framework, which emphasizes responsible operations and a commitment to environmental stewardship. The company has been recognized for its efforts with various sustainability certifications and is actively working towards achieving carbon neutrality in its operations.

Amgen's sustainability initiatives include investments in renewable energy, improvements in energy efficiency, and the implementation of sustainable practices across its supply chain. The company also engages in transparent reporting of its sustainability performance, providing stakeholders with insights into its progress and challenges. Despite these efforts, there is limited publicly available information on specific carbon footprint calculations or detailed sustainability accreditations.